SYNAGIS sol inj 50 mg/0.5ml flac
7680656950015
CH-65695
J06BD01
08.03.0.
Reimbursement limitations:
SYNAGIS5
La prise en charge des coûts de Synagis au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6569501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- palivizumabum 50 mg, histidinum, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.
Articles (1)
Synagis 50 mg/0.5 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 624.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2017
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 65695
- Drug name
- Synagis, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- J06BD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/07/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SYNAGIS sol inj 50 mg/0.5ml flac
- Description (DE)
- SYNAGIS Inj Lös 50 mg/0.5ml Durchstf
- Market launch
- 05/07/2016
- Narcotic (BTM)
- No